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Background: Reported concentrations of serotonin in platelet-poor plasma (PPP) in healthy subjects
vary widely due to different pre-analytical procedures.
Aim: To examine how different pre-analytical conditions affect the measured concentration of
serotonin in PPP.
Method: Six pre-analytical protocols were compared for preparation of PPP from EDTA whole
blood for quantification of serotonin from nine healthy individuals. Three combinations of
centrifugation with a mild centrifugation of gel-free EDTA tubes followed by a stronger centri-
fugation were compared to single-stage centrifugation of EDTA tubes with separator gel and heat
shock treatment of blood prior to centrifugation. All samples were analysed using the same
enzyme linked immunosorbent assay (ELISA) method.
Results: Findings show that two consecutive centrifugations; first a mild centrifugation at 100 or
200g followed by centrifugation at 4500 or 14500g resulted in the lowest serotonin concen-
tration in PPP.
Conclusion: Two successive centrifugations to produce PPP for serotonin analysis; first a mild
centrifugation to avoid mechanical stress on the platelets, and next a stronger centrifugation to
remove platelets, is superior to the use of gel tubes and heat shock treatment.1. Introduction
Serotonin (5-hydroxytryptamine) is an important neurotransmitter and neuromodulator which affects many neurophysiological
processes, mood and cognition, regulates motility and sensibility in the bowel, and has an essential role in regulating blood pressure [1].
Merely 1–2% of the essential amino acid L-tryptophan from dietary intake is metabolized to serotonin in humans, whereas most of the
ingested L-tryptophan is metabolized through the kynurenine pathway [2]. Serotonin in blood is primarily originating from biosynthesis
in the gastrointestinal tract, and after secretion serotonin is rapidly taken up and is transported in platelets, with free circulating se-
rotonin representing only a minor fraction of the total serotonin amount in blood [3].
Since only free plasma serotonin can bind to serotonin receptors and exert biological activity [4], it is important to have a reliableScience, University of Bergen, 5021, Bergen, Norway.
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collection of blood, platelets are exposed to both mechanical and thermal stress; several aspects such as the cannula diameter, blood
flow, anti-coagulant, pipetting, change in temperature and conditions during centrifugation (temperature, force and time) may affect the
release of serotonin from the blood platelets [5,6]. As a consequence of this, reported concentrations of serotonin in PPP may vary
widely due to differences in pre-analytical procedures [4]. The aim of this investigation was to examine how different pre-analytical
conditions may affect the measured concentration of serotonin in PPP from healthy volunteers, and to identify the pre-analytical
protocol resulting in the lowest PPP serotonin concentration.
2. Methods
2.1. Participants, study setting and ethics
Blood samples were collected from nine healthy adults recruited at Haukeland University Hospital, Bergen, Norway in September
2015. Examinations were conducted at Haukeland University Hospital. The study was conducted according to the guidelines laid down
in the Declaration of Helsinki and all procedures were approved by the Regional Committee for Medical and Health Research Ethics of
Western Norway (REC-number: 2014/2222). Written informed consent was obtained from all subjects. All data were analysed
anonymously.
2.2. Protocol for study visits
The participants attended one study visit. Examinations were conducted in the morning after an overnight fast. The subjects were
instructed not to eat or drink anything except water after 22.00 the previous day, to avoid intake of serotonin-rich food such as bananas,
ice-cream, nuts, chocolate, tomato and kiwi for 72 h before the visit, to avoid drinking coffee or alcohol and smoking cigarettes for 24 h
prior to the visit. Blood was drawn from an antecubital vein and was collected in 3ml VACUETTE® K2EDTA tubes and 5ml VACU-
ETTE® K2EDTA gel tubes (Greiner Bio-one) for isolation of plasma, all tubes had a final EDTA concentration of 4.429mmol/L.
2.3. Preparation of platelet-poor plasma (PPP)
PPP was prepared separately from blood samples from each of nine participant using six different pre-analytical procedures as shown
in Table 1. Blood was collected in tubes in the order A to F for each sampling. All blood samples were centrifuged within 5min after
collection, and PPP was stored at 80 C until analysed.
2.4. Analyses of serotonin in PPP
Serotonin was quantified using competitive ELISA (#RE59121, IBL International GmbH, Hamburg, Germany). Acylated samples
were incubated overnight with serotonin biotin and serotonin antiserum (rabbit) on a microtiter plate coated with anti-rabbit antiserum.
Bound biotinylated serotonin was determined by use of streptavidin alkaline phosphatase (marker) and p-nitrophenyl phospahte
(substrate). Samples were analysed in duplicate or triplicate. The inter assay coefficient of variation, which was tested using a quality
control solution (13.2 ng/mL, provided with the kit) in triplicate from 3 plates, was 7.4%, and the mean coefficient of variation for eachTable 1
Overview of the preparation methods of platelet-poor plasma for serotonin analyses.
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2.5. Statistical analyses
Statistical analyses were conducted using SPSS Statistics 25 (SPSS, Inc., IBM Company). Normality of data was tested by Shapiro
Wilks test. Measured serotonin concentrations were compared using one-way ANOVA followed by Tukey post-hoc test. Data are
expressed as mean with standard deviation (SD). P< 0.05 was considered statistically significant.
3. Results
3.1. Comparison of different pre-analytical conditions on PPP serotonin concentrations
Table 2 shows the measured serotonin concentrations in PPP with different pre-analytical conditions. Preparation methods were
compared using one-way ANOVA (p 1.2 1012) and the Tukey post-hoc test demonstrated that serotonin concentrations in PPP
prepared by method E was significantly different from PPP prepared by all other methods (p< 1 107 for all individual comparisons
including method E, data not presented). To achieve a better discrimination between results from the other pre-analytical methods,
results from method E was omitted and the ANOVA analysis was repeated (p ANOVA 1.4 104). This showed that serotonin con-
centrations were significantly lower in PPP prepared by methods A, B and C when compared to those prepared by methods D and F, with
no significant differences between measured serotonin concentrations between methods A, B and C, and no significant differences
between methods D and F.
4. Discussion
This is the first study to compare different centrifugation conditions on measured serotonin concentrations in PPP from healthy
volunteers, without varying blood sampling techniques and type of anticoagulant added to identify the most suitable pre-analytical
conditions for PPP serotonin quantification by ELISA. Three previously reported methods using double-stage centrifugation [7–9]
and three alternative singel-stage centrifugation methods using separation gel or heat shock treatment for preparing PPP were
compared. This work demonstrates that a combination of a milder first centrifugation of gel-free EDTA-tubes to separate blood cells (100
or 200g) followed by a stronger centrifugation of the supernatant (4500 or 14500g) resulted in the lowest measured serotonin
concentration in PPP.
It is well known that the liberation of serotonin from platelets to plasma is affected by both thermal and mechanical conditions [5,6],
and as a consequence reported serotonin concentrations in PPP vary widely in the literature [4]. Comparisons of different pre-analytical
and analytical factors on the measured PPP serotonin concentrations have been published [4,8]. In the present study we compare
different pre-analytical protocols for PPP from healthy adults before analyses using ELISA, thus making it easier to identify the best
pre-analytical protocol for quantification of serotonin in PPP. In the largest overview of published concentrations of serotonin in PPP
from healthy subjects published to date, Brand and Anderson [4] demonstrate a huge variation in reported serotonin values from 101
studies, ranging from 0.1 to 31.6 ng/mL, and the authors suggest an upper limit of PPP serotonin of 1 ng/ml. However, since the
analytical method in use strongly impacted the resulting serotonin concentration, e.g., radioenzymatic assay and mass spectrometry
typically produce lower results compared to ELISA, this upper limit should be interpreted with great care. In the present study we
compared different pre-analytical methods described in publications that presents low serotonin concentrations in PPP from healthy
individuals; Yubero-Lahoz et al. [8] reporting a mean serotonin PPP concentration of 0.62 0.12 ng/mL (N¼ 15), Lederer et al. [10],
who prepared PPP as advised by IBL [7], reported a mean plasma serotonin concentration of 0.11 ng/mL (N¼ 6) and Frost et al. [9]
reportedmean serotonin PPP concentration of 3.51± 0.49 ng/mL (N¼ 18). We do however suspect that there may be a calculation error
in the paper by Lederer et al. [10], since Lederer et al. give the value as 1.3 nmol/L when discussing the 97th percentile value given in
the IBL kit literature, when it is actually stated as 7.5 ng/mL by IBL (equal to 42.5 nmol/L, using the correct conversion factor of 5.67 to
go from ng/mL to nmol/L). Thus, it appears that when converting from ng/mL to nmol/L, Lederer et al. divided their ng/mL results byTable 2
Measured serotonin concentrations in platelet-poor plasma from healthy donors (N¼ 9).







Serotonin concentration is presented as mean standard deviation. Serotonin concentrations in PPP prepared by
method E was discarded from statistical analysis since results deviated strongly from results obtained with the other pre-
analytical methods.
1Methods A, B, C, D and F are compared using one-way ANOVA (p¼ 1.4 104) with Tukey post-hoc test; means in a
column with different letters are significantly different (p< 0.05).
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20 nmol/L (~3.5 ng/mL).
The protocol with heat shocking of the platelets were inspired by the paper by Maurer-Spurej et al. [11], who demonstrated that
moderate heat shock conditions (42 C for 10min) caused no signs of platelet activation, whereas room temperature causes marked
activation of platelets and affected platelet serotonin content.
Plasma serotonin concentration has been shown to increase by >300% after 40min on ice compared to immediate centrifugation
[12]. This motivated us to test EDTA-tubes with gel to achieve rapid separation of blood cells and plasma with only one centrifugation
(1800g for 15min, with temperatures 4 C or 22 C), as these gel tubes are commonly used in the clinic and would be convenient to
implement in the daily routine.
Our results show that two consecutive centrifugations resulted in the lowest measured serotonin concentrations in PPP (methods A, B
and C), probably because these protocols include is a milder method for separation of blood cells in the first centrifugation step (100-
200g) that causes less stress on the blood platelets and thus less serotonin liberation from the platelets. Of these three methods tested,
methods A and C seem to be the superior methods, probably because the second centrifugation (4500 and 14500g, respectively)
removed platelets to a larger degree compared to method B (550g), Thus, the lowest measured serotonin mean concentration were 0.9
(SD 0.5) and 1.0 (SD 0.5) ng/mL, for method A and C, respectively. The use of heat shock (method D) did not prevent serotonin
liberation from the platelets, and measured serotonin values were higher when compared to methods A, B and C.
The use of EDTA tubes with separator gel resulted in very high serotonin concentrations when gel tubes were centrifuged at 4 C
(method E), with large variations between the samples. Also, when gel tubes were centrifuged at 22 C (method F), mean serotonin
concentration was higher compared to methods A, B and C, but concentration was lower compared to method E, however with small
variations between the samples. These findings suggest that either the use of gel tubes somehow activated the platelets, or that the gel
was not sufficiently effective in separating blood platelets from plasma, especially when centrifuged at 4 C.
In conclusion, two consecutive centrifugations of EDTA-blood; first a mild centrifugation at 100 or 200g followed by a stronger
centrifugation at 4500 or 14500g at 4 C, resulted in the lowest PPP serotonin concentrations, regardless of whether first centrifu-
gation temperature was 4 C or 22 C, and are superior to the use of gel tubes and heat shock treatment. Our interpretation is that the
first centrifugation induced little mechanical stress on the blood platelets and the second centrifugation was sufficiently strong to
prevent contamination of platelets in the PPP fraction.
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